The University Hospital Centre in Zagreb, Croatia, is the largest hospital in Croatia and the teaching hospital of the University of Zagreb. It serves most of Central and Northern Croatia for specialist and acute medical procedures.

There are 1,800 beds in University hospital centre Zagreb.

During the past decade, University hospital centre Zagreb conducted 121 clinical trials. In the 10-year time frame, 121 clinical trials started and 79 clinical trials were completed, i.e. on average, 65.3% percent of trials that started reached the finish line to date. In the past 5 years, 43 clinical trials started and 47 clinical trials were completed. i.e. 109.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University hospital centre Zagreb" #1 sponsor was "Hoffmann-La Roche" with 31 trials, followed by "European Organisation for Research and Treatment of Cancer - EORTC" with 15 trials sponsored, "Pfizer" with 14 trials sponsored, "Clinical Hospital Centre Zagreb" with 11 trials sponsored and "University of Zagreb" with 11 trials sponsored. Other sponsors include 115 different institutions and companies that sponsored additional 76 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University hospital centre Zagreb" #1 collaborator was "Clinical Hospital Centre Zagreb" with 5 trials as a collaborator, "Bayer" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "Gruppo Italiano Malattie EMatologiche dell'Adulto" with 3 trials as a collaborator and "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator. Other collaborators include 60 different institutions and companies that were collaborators in the rest 64 trials.

According to Clinical.Site data, the most researched conditions in "University hospital centre Zagreb" are "Ulcerative Colitis" (13 trials), "Crohn's Disease" (11 trials), "Leukemia" (10 trials), "Breast Cancer" (8 trials) and "Multiple Sclerosis" (6 trials). Many other conditions were trialed in "University hospital centre Zagreb" in a lesser frequency.

Most popular intervention types in "University hospital centre Zagreb" are "Drug" (149 trials), "Biological" (24 trials), "Procedure" (20 trials), "Other" (18 trials) and "Device" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (47 trials), "cytarabine" (8 trials), "Cyclophosphamide" (7 trials), "cyclophosphamide" (7 trials) and "Atezolizumab" (6 trials). Other intervention names were less common.

The vast majority of trials in "University hospital centre Zagreb" are 188 trials for "All" genders, 10 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are 57 active trials in "University hospital centre Zagreb". 1 are not yet recruiting, 30 are recruiting, 24 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 103 completed trials in University hospital centre Zagreb, undefined suspended trials, and 24 terminated clinical trials to date.

Out of the total trials that were conducted in University hospital centre Zagreb, 6 "Phase 1" clinical trials were conducted, 27 "Phase 2" clinical trials and 121 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 11 trials, and there were also 16 trials that are defined as “Not Applicable".